StockMacro
Company, fund or insider

Help

Menu

Nutex Health

$162.64 +32% in 6 monthsMarket cap $1.1B

NUTX on XNAS, Services, Nutex Health Inc., job postings

Measures activity, not value. Not investment advice.

Revenue fell 19% to $217.6M in the latest quarter, and a cyber incident report was filed.

  • BadShort interest 17% of shares, 10.1 days to cover
  • WatchNet income up 37% to $164.7M, though 12-month revenue fell 19%

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Nutex Health Inc is a physician-led, healthcare services and operations company with various hospital facilities in the U.S. states (hospital division), and a primary care-centric, risk-bearing population health management division. The company has three segments: the hospital division, the PHM division, and the real estate division. The hospital division implements and operates health care models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management (PHM) division owns and operates provider networks such as independent physician associations (IPAs). The Real Estate Entities own the land and hospital buildings which are leased to its hospital entities. The majority of the revenue is derived from the Hospital division.

Industry
Services-business services, nec (Services)
Employees
944
Website
nutexhealth.com
Listed
Nasdaq, US
Last results
5 Nov 2026
Next results
expected around 4 Mar 2027 (an estimate: a year ago it reported on 5 Mar 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $217.6M, net income $40.2M.
Quarter to 31 Dec 2021: revenue $5.9M, net income -$4.6MQuarter to 31 Dec 2021: revenue $5.9M, net income -$4.6MQuarter to 31 Mar 2022: revenue $6.2M, net income -$16.6MQuarter to 31 Mar 2022: revenue $6.2M, net income -$16.6MQuarter to 30 Jun 2022: revenue $58.0M, net income -$23.5MQuarter to 30 Jun 2022: revenue $58.0M, net income -$23.5MQuarter to 30 Sep 2022: revenue $29.0M, net income -$433.2MQuarter to 30 Sep 2022: revenue $29.0M, net income -$433.2MQuarter to 31 Dec 2022: revenue $53.7M, net income -$14.8MQuarter to 31 Dec 2022: revenue $53.7M, net income -$14.8MQuarter to 31 Mar 2023: revenue $56.3M, net income -$5.1MQuarter to 31 Mar 2023: revenue $56.3M, net income -$5.1MQuarter to 30 Jun 2023: revenue $58.9M, net income -$3.5MQuarter to 30 Jun 2023: revenue $58.9M, net income -$3.5MQuarter to 30 Sep 2023: revenue $62.7M, net income -$5.5MQuarter to 30 Sep 2023: revenue $62.7M, net income -$5.5MQuarter to 31 Dec 2023: revenue $69.7M, net income -$31.6MQuarter to 31 Dec 2023: revenue $69.7M, net income -$31.6MQuarter to 31 Mar 2024: revenue $67.5M, net income -$364KQuarter to 31 Mar 2024: revenue $67.5M, net income -$364KQuarter to 30 Jun 2024: revenue $76.1M, net income -$364KQuarter to 30 Jun 2024: revenue $76.1M, net income -$364KQuarter to 30 Sep 2024: revenue $78.8M, net income -$8.8MQuarter to 30 Sep 2024: revenue $78.8M, net income -$8.8MQuarter to 31 Dec 2024: revenue $257.6M, net income $61.7MQuarter to 31 Dec 2024: revenue $257.6M, net income $61.7MQuarter to 31 Mar 2025: revenue $211.8M, net income $14.6MQuarter to 31 Mar 2025: revenue $211.8M, net income $14.6MQuarter to 30 Jun 2025: revenue $244.0M, net income -$17.7MQuarter to 30 Jun 2025: revenue $244.0M, net income -$17.7MQuarter to 30 Sep 2025: revenue $267.8M, net income $55.4MQuarter to 30 Sep 2025: revenue $267.8M, net income $55.4MQuarter to 31 Dec 2025: revenue $151.7M, net income $11.8MQuarter to 31 Dec 2025: revenue $151.7M, net income $11.8MQuarter to 31 Mar 2026: revenue $216.5M, net income $46.8MQuarter to 31 Mar 2026: revenue $216.5M, net income $46.8MQuarter to 30 Jun 2026: revenue $210.8M, net income $65.8MQuarter to 30 Jun 2026: revenue $210.8M, net income $65.8MQuarter to 30 Sep 2026: revenue $217.6M, net income $40.2MQuarter to 30 Sep 2026: revenue $217.6M, net income $40.2M
31 Dec 2021RevenueNet incomeNet losstallest bar $433.2M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$217.6M$40.2M
30 Jun 2026$210.8M$65.8M
31 Mar 2026$216.5M$46.8M
31 Dec 2025$151.7M$11.8M
30 Sep 2025$267.8M$55.4M
30 Jun 2025$244.0M-$17.7M
31 Mar 2025$211.8M$14.6M
31 Dec 2024$257.6M$61.7M
30 Sep 2024$78.8M-$8.8M
30 Jun 2024$76.1M-$364K
31 Mar 2024$67.5M-$364K
31 Dec 2023$69.7M-$31.6M
30 Sep 2023$62.7M-$5.5M
30 Jun 2023$58.9M-$3.5M
31 Mar 2023$56.3M-$5.1M
31 Dec 2022$53.7M-$14.8M
30 Sep 2022$29.0M-$433.2M
30 Jun 2022$58.0M-$23.5M
31 Mar 2022$6.2M-$16.6M
31 Dec 2021$5.9M-$4.6M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $796.5M $981.2M
Revenue growthRevenue of the last 12 months compared with the 12 months before. -19% +9.7%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $164.7M $120.7M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $23.95 $19.26
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 47.8% 55.0% 40.4%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 39.0% 36.6% 7.8%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 20.7% 12.3% 5.9%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 43.8% 10.2%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $248.1M $176.3M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $249.9M $166.0M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $42.3M $43.6M
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$207.6M (net cash) -$122.5M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.10 0.57
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $63.49
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 6.8 25.0
P/SPrice to sales: market cap divided by revenue of the last 12 months. 1.4 1.5
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 1.1 1.8
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 2.6 2.4

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Nutex HealthNUTX (this company) $1.1B6.81.4-19%20.7%
AndersenANDG $1.1Bloss1.2–-8.0%
QuinStreetQNST $1.1B11.30.74+29%6.6%
Liquidity ServicesLQDT $1.0B26.82.1+0.3%7.8%
MediaAlphaMAX $784.0M7.30.61+15%8.4%
PhreesiaPHR $708.2M67.81.4+13%2.1%

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

-19%

$217.6M vs $267.8M (quarter ended 30 Sep 2026)

Insider buy/sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$43K

bought $0, sold $43K

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+21%

182 13F filers vs 150

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

46%

3.2M shares held by 13F filers (30 Sep 2026) of 6.9M outstanding (2 Nov 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

17%

1.2M shares sold short (30 Oct 2026) of 6.9M outstanding (2 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

10.1

1.2M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-5.9%

1.2M shares sold short in the report before, 1.2M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

69%

69% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 68%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

117

Tracked since 21 Nov 2026

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

Tracking started 21 Nov 2026; the change shows after 30 days.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

1,093

reported for the year to 30 Sep 2026; +24% on the year before (880)

News Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

14

14 articles in the last 7 days; its usual week has 3 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

4.7×

14 articles in the last 7 days; its usual week has 3.

Unusual now sharp changes in the last 90 days, compared with its own past

  • Capital spending $5.2M, 17× a year earlier

Price $162.64 on 20 Nov 2026, +14% over 12 months (12-month range $87.01 to $225.00)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders bought a net $2K in the last 12 months (the 12 months before: $184K).
Revenue per quarter. Revenue $217.6M in the latest quarter, -19% on a year earlier.
Capital spending per quarter. Capital spending $5.2M in the latest quarter, +1623% on a year earlier.
Institutional holders (13F filers). 182 13F filers reported holding it in the latest 13F quarter, +98% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
10 Nov 2026Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 5.2M vs usual 684K (2026-09-30); 17.2x the same period a year earlier
31 Aug 20268-K and other filingsMaterial cybersecurity incident
2 Dec 2025Sharp changeShort interest spike: short interest spike, 806K vs usual 164K (2025-11-14); 21.4x the same period a year earlier
20 Nov 2025Sharp changeQuarterly revenue change: quarterly revenue change, 267.8M vs usual 77.4M (2025-09-30); 3.4x the same period a year earlier
18 Nov 2025Sharp changeMany funds opening a new position: many funds opening a new position, 28 vs usual 8 (2025-09-30); 2.8x the same period a year earlier
18 Nov 2025Sharp changeShort interest spike: short interest spike, 839K vs usual 112K (2025-10-31); 23.5x the same period a year earlier
17 Nov 20258-K and other filingsReport will be filed late
28 Oct 2025Sharp changeShort interest spike: short interest spike, 949K vs usual 102K (2025-10-15); 9.7x the same period a year earlier
20 Oct 20258-K and other filingsDelisting notice or listing transfer
14 Oct 2025Sharp changeShort interest spike: short interest spike, 1.0M vs usual 102K (2025-09-30); 6.9x the same period a year earlier
30 Sep 2025Sharp changeShort interest spike: short interest spike, 1.0M vs usual 102K (2025-09-15); 8.2x the same period a year earlier
22 Sep 20258-K and other filingsDirector or officer change
16 Sep 2025Sharp changeShort interest spike: short interest spike, 1.1M vs usual 102K (2025-08-29); 8.8x the same period a year earlier
4 Sep 20258-K and other filingsDirector or officer change
2 Sep 2025Sharp changeShort interest spike: short interest spike, 892K vs usual 100K (2025-08-15); 8.8x the same period a year earlier
20 Aug 20258-K and other filingsEarlier financial statements can no longer be relied on
20 Aug 20258-K and other filingsDelisting notice or listing transfer
14 Aug 2025Sharp changeMany funds opening a new position: many funds opening a new position, 55 vs usual 8 (2025-06-30)
14 Aug 20258-K and other filingsReport will be filed late
12 Aug 2025Sharp changeShort interest spike: short interest spike, 905K vs usual 91K (2025-07-31); 12.1x the same period a year earlier
29 Jul 2025Sharp changeShort interest spike: short interest spike, 818K vs usual 91K (2025-07-15); 7.5x the same period a year earlier
11 Jul 20258-K and other filingsDirector or officer change
11 Jul 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
21 May 20258-K and other filingsChanged its auditor
15 May 2025Sharp changeQuarterly revenue change: quarterly revenue change, 211.8M vs usual 68.6M (2025-03-31); 3.1x the same period a year earlier
25 Apr 20258-K and other filingsChanged its auditor
1 Apr 2025Sharp changeQuarterly revenue change: quarterly revenue change, 257.6M vs usual 65.1M (2024-12-31); 3.7x the same period a year earlier
18 Jun 20248-K and other filingsDelisting notice or listing transfer
24 May 20248-K and other filingsDelisting notice or listing transfer
8 Apr 20248-K and other filingsDirector or officer change
15 Mar 20248-K and other filingsReport will be filed late
29 Feb 20248-K and other filingsDirector or officer change
15 Feb 20248-K and other filingsA major agreement ended
9 Feb 20248-K and other filingsDirector or officer change
9 Feb 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
27 Nov 20238-K and other filingsDelisting notice or listing transfer
17 Oct 20238-K and other filingsPrivate placement of securities (Form D)
5 Sep 20238-K and other filingsDirector or officer change
5 Jul 20238-K and other filingsDirector or officer change
5 Jul 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
16 Jun 2023Sharp changeClustered insider buying: clustered insider buying (5 independent filers, 5 filing(s) in 30 days, value_usd total 578K)
26 May 20238-K and other filingsDelisting notice or listing transfer
16 May 2023Sharp changeShort interest spike: short interest spike, 12.3M vs usual 3.1M (2023-04-28); 13.0x the same period a year earlier
16 May 2023Sharp changeQuarterly revenue change: quarterly revenue change, 56.3M vs usual 6.1M (2023-03-31); 9.1x the same period a year earlier
11 May 20238-K and other filingsReport will be filed late
2 May 2023Sharp changeShort interest spike: short interest spike, 12.4M vs usual 3.0M (2023-04-14); 1556.8x the same period a year earlier
5 Apr 20238-K and other filingsDirector or officer change
5 Apr 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
7 Mar 2023Sharp changeQuarterly revenue change: quarterly revenue change, 53.7M vs usual 5.7M (2022-12-31); 9.1x the same period a year earlier
2 Mar 20238-K and other filingsReport will be filed late
4 Jan 20238-K and other filingsDirector or officer change
4 Jan 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
22 Nov 2022Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 5.9M vs usual 0 (2022-09-30); 1.7x the same period a year earlier
22 Nov 2022Sharp changeQuarterly revenue change: quarterly revenue change, 29.0M vs usual 5.4M (2022-09-30); 5.2x the same period a year earlier
15 Nov 20228-K and other filingsReport will be filed late
23 Aug 2022Sharp changeQuarterly revenue change: quarterly revenue change, 58.0M vs usual 3.7M (2022-06-30); 11.0x the same period a year earlier
15 Aug 20228-K and other filingsReport will be filed late
10 Jun 20228-K and other filingsDirector or officer change
26 Apr 20228-K and other filingsDirector or officer change
12 Apr 20228-K and other filingsPrivate placement of securities (Form D)
4 Apr 20228-K and other filingsDirector or officer change
4 Apr 20228-K and other filingsCompleted an acquisition or asset sale
4 Apr 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
24 Nov 20218-K and other filingsDirector or officer change
Insider net buying (open market)
Month from 1 Sep 2022: -$2.1M published
Month from 1 Dec 2022: -$368K published
Month from 1 May 2023: $547K published
Month from 1 Jun 2023: $39K published
Month from 1 Sep 2023: $296K published
Month from 1 Nov 2023: $149K published
Month from 1 May 2024: $50K published
Month from 1 Jun 2024: $11K published
Month from 1 Aug 2024: $62K published
Month from 1 Apr 2025: $82K published
Month from 1 Nov 2025: $103K published
Month from 1 Mar 2026: $46K published
Month from 1 Sep 2026: -$43K published
Revenue per quarter
Quarter ended 31 Dec 2021: $5.9M, +1411% on a year earlier; public on 1 Apr 2022
Quarter ended 31 Mar 2022: $6.2M, +208% on a year earlier; public on 14 May 2022
Quarter ended 30 Jun 2022: $58.0M, +997% on a year earlier; public on 23 Aug 2022
Quarter ended 30 Sep 2022: $29.0M, +421% on a year earlier; public on 22 Nov 2022
Quarter ended 31 Dec 2022: $53.7M, +807% on a year earlier; public on 4 Mar 2023
Quarter ended 31 Mar 2023: $56.3M, +807% on a year earlier; public on 16 May 2023
Quarter ended 30 Jun 2023: $58.9M, +1.5% on a year earlier; public on 10 Aug 2023
Quarter ended 30 Sep 2023: $62.7M, +116% on a year earlier; public on 10 Nov 2023
Quarter ended 31 Dec 2023: $69.7M, +30% on a year earlier; public on 30 Mar 2024
Quarter ended 31 Mar 2024: $67.5M, +20% on a year earlier; public on 10 May 2024
Quarter ended 30 Jun 2024: $76.1M, +29% on a year earlier; public on 9 Aug 2024
Quarter ended 30 Sep 2024: $78.8M, +26% on a year earlier; public on 8 Nov 2024
Quarter ended 31 Dec 2024: $257.6M, +270% on a year earlier; public on 1 Apr 2025
Quarter ended 31 Mar 2025: $211.8M, +214% on a year earlier; public on 14 May 2025
Quarter ended 30 Jun 2025: $244.0M, +221% on a year earlier; public on 19 Nov 2025
Quarter ended 30 Sep 2025: $267.8M, +240% on a year earlier; public on 20 Nov 2025
Quarter ended 31 Dec 2025: $151.7M, -41% on a year earlier; public on 6 Mar 2026
Quarter ended 31 Mar 2026: $216.5M, +2.2% on a year earlier; public on 1 May 2026
Quarter ended 30 Jun 2026: $210.8M, -14% on a year earlier; public on 7 Aug 2026
Quarter ended 30 Sep 2026: $217.6M, -19% on a year earlier; public on 6 Nov 2026
Capital spending per quarter
Quarter ended 31 Mar 2021: $0; public on 14 May 2022
Quarter ended 30 Jun 2021: $21.7M; public on 23 Aug 2022
Quarter ended 30 Sep 2021: $3.5M; public on 22 Nov 2022
Quarter ended 31 Mar 2022: $1K; public on 14 May 2022
Quarter ended 30 Jun 2022: $8.0M, -63% on a year earlier; public on 10 Aug 2023
Quarter ended 30 Sep 2022: $5.9M, +69% on a year earlier; public on 22 Nov 2022
Quarter ended 31 Mar 2023: $4.4M, +307705% on a year earlier; public on 16 May 2023
Quarter ended 30 Jun 2023: $3.1M, -62% on a year earlier; public on 10 Aug 2023
Quarter ended 31 Mar 2024: $733K, -83% on a year earlier; public on 19 Nov 2025
Quarter ended 30 Jun 2024: $559K, -82% on a year earlier; public on 19 Nov 2025
Quarter ended 30 Sep 2024: $617K; public on 20 Nov 2025
Quarter ended 31 Dec 2024: $395K; public on 19 Nov 2025
Quarter ended 31 Mar 2025: $64K, -91% on a year earlier; public on 19 Nov 2025
Quarter ended 30 Jun 2025: $751K, +34% on a year earlier; public on 19 Nov 2025
Quarter ended 30 Sep 2025: $302K, -51% on a year earlier; public on 20 Nov 2025
Quarter ended 31 Dec 2025: $1.4M, +257% on a year earlier; public on 6 Mar 2026
Quarter ended 31 Mar 2026: $1.2M, +1777% on a year earlier; public on 1 May 2026
Quarter ended 30 Jun 2026: $2.5M, +238% on a year earlier; public on 7 Aug 2026
Quarter ended 30 Sep 2026: $5.2M, +1623% on a year earlier; public on 6 Nov 2026
Institutional holders (13F filers)
30 Jun 2022 report: 51; public on 15 Aug 2022
30 Sep 2022 report: 50; public on 14 Nov 2022
31 Dec 2022 report: 71; public on 14 Feb 2023
31 Mar 2023 report: 83; public on 15 May 2023
30 Jun 2023 report: 71; public on 14 Aug 2023
30 Sep 2023 report: 55; public on 14 Nov 2023
31 Dec 2023 report: 44; public on 14 Feb 2024
31 Mar 2024 report: 47; public on 15 May 2024
30 Jun 2024 report: 21; public on 14 Aug 2024
30 Sep 2024 report: 27; public on 14 Nov 2024
31 Dec 2024 report: 40; public on 14 Feb 2025
31 Mar 2025 report: 46; public on 15 May 2025
30 Jun 2025 report: 96; public on 14 Aug 2025
30 Sep 2025 report: 92; public on 14 Nov 2025
31 Dec 2025 report: 110; public on 17 Feb 2026
31 Mar 2026 report: 124; public on 15 May 2026
30 Jun 2026 report: 150; public on 14 Aug 2026
30 Sep 2026 report: 182; public on 16 Nov 2026

What is unusual now

  • Made public in the last 90 days: it spent $5.2M on capital projects in the quarter ended 30 Sep 2026, 17× the same quarter last year.
  • Quarterly capital spending jump: spent $5.2M on capital projects in the quarter ended 30 Sep 2026, 17× the same quarter last year Public on 10 Nov 2026.
  • Insider net buying (open market): Insiders bought a net $2K in the last 12 months (the 12 months before: $184K).
  • Revenue per quarter: Revenue $217.6M in the latest quarter, -19% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 33 insider trades

Last 90 days: 1 sale, $43K; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
18 Sep 2026Scott J SaundersDirectorSell203$214.25$43KForm 4
23 Mar 2026Frank E JaumotDirectorBuy150$93.56$14KForm 4
23 Mar 2026Warren HosseinionPresidentBuy252$94.07$24KForm 4
18 Mar 2026Kelvin SpearsDirectorBuy10$94.46$945Form 4
16 Mar 2026Pamela W. MontgomeryChief Legal Officer-HealthcareBuy79$88.87$7KForm 4
28 Nov 2025Jon Christian BatesChief Financial OfficerBuy750$136.71$103KForm 4
14 Apr 2025Jon Christian BatesChief Financial OfficerBuy1,000$81.81$82KForm 4
26 Aug 2024Jon Christian BatesChief Financial OfficerBuy1,350$21.46$29KForm 4

182 institutions reported shares at the end of Q3 2026, 46% of the shares outstanding; 40 opened a position, 13 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
Pertento Partners LLP519K7.57%$109.9M+68K+15%
BlackRock, Inc.394K5.75%$83.4M-13K-3.2%
American Century Companies Inc324K4.72%$68.5M+86K+36%
Vanguard Capital Management LLC198K2.89%$41.9M-18K-8.2%
State Street Corp135K1.97%$28.6M+4,511+3.4%
Geode Capital Management, LLC127K1.85%$26.9M-4,864-3.7%
UBS Group AG82K1.19%$17.3M+3,920+5.0%
D. E. Shaw & Co., Inc.72K1.06%$15.3M-25K-26%
Winmill & Co. Inc65K0.95%$13.8MNo change
Empowered Funds, LLC57K0.83%$12.0M+12K+26%

Company events

All 98 company events

In 12 months: 1 major agreement, 1 cybersecurity incident. Results releases and routine reports are left out.

FiledWhat happenedSource
31 Aug 2026Material cybersecurity incident8-K
21 Jul 2026Signed a major agreement8-K
17 Nov 2025Quarterly report will be filed lateNT 10-Q
20 Oct 2025Delisting notice or listing transfer8-K
22 Sep 2025Director or officer change8-K
4 Sep 2025Director or officer change8-K
20 Aug 2025Delisting notice or listing transfer; Earlier financial statements can no longer be relied on8-K
14 Aug 2025Quarterly report will be filed lateNT 10-Q

117 open postings; careers site tracked since 21 Nov 2026. Most in Sales & business development 3%, Finance & accounting 2%, Corporate IT 2%, Operations & administration 2%.

PostedJobLocation
21 Nov 2026or earlierRadiology Technologist MultimodalityTucson ER & Hospital
21 Nov 2026or earlierIT Help Desk SpecialistCorporate ITNutex Health Inc.
21 Nov 2026or earlierMRI TechnicianMilwaukee ER & Hospital
21 Nov 2026or earlierParamedicTucson ER & Hospital
21 Nov 2026or earlierRegistered NurseFort Smith ER & Hospital
21 Nov 2026or earlierMRI TechnologistStarkey Ranch ER & Hospital
21 Nov 2026or earlierPatient Care TechBayou City ER & Hospital
21 Nov 2026or earlierRegistered NurseEast Valley ER & Hospital

The 5 newest of 137 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

14 Aug 2025confirmed

Confirmed across sources Institutional holdings and Filings + Financials and Short interest and volume

Nutex Health (NUTX): saw 55 13F filers open a new position in the quarter ended 30 Jun 2025, against none in the same quarter last year; it also had 949K shares sold short in the 15 Oct 2025 report, 9.7× the same report last year; and it reported revenue of $267.8M for the quarter ended 30 Sep 2025, 3.4× the same quarter last year. Three unrelated kinds of activity within 126 days.

  • Short interest and volume: Short interest spike, became public on 25 Jul 2025
  • Short interest and volume: Short interest spike, became public on 12 Aug 2025
  • Institutional holdings: Many funds opening a new position, became public on 14 Aug 2025
  • Short interest and volume: Short interest spike, became public on 27 Aug 2025
  • Short interest and volume: Short interest spike, became public on 11 Sep 2025
  • Short interest and volume: Short interest spike, became public on 25 Sep 2025
  • Short interest and volume: Short interest spike, became public on 10 Oct 2025
  • Short interest and volume: Short interest spike, became public on 25 Oct 2025
  • Institutional holdings: Many funds opening a new position, became public on 14 Nov 2025
  • Short interest and volume: Short interest spike, became public on 13 Nov 2025
  • Financials: Quarterly revenue change, became public on 20 Nov 2025
  • Short interest and volume: Short interest spike, became public on 26 Nov 2025
2023-06-30: 182023-09-30: 72023-12-31: 72024-03-31: 52024-06-30: 02024-09-30: 102024-12-31: 152025-03-31: 92025-06-30: 55
The quarter ended 30 Jun 2025 against the 8 quarters before it. this quarterearliernormal: 8
See the evidence (12 changes)

Short interest and volume: Short interest spike became public on 25 Jul 2025

Nutex Health had 818K shares sold short in the 15 Jul 2025 report, 7.5× the same report last year.

This period
818K (the 15 Jul 2025 report)
Normal report (median of 24 earlier)
91K
Typical spread (median absolute deviation)
38K
How far from its usual level
+12.7
Same report last year
108K
History used
1,188 days
2024-07-15: 108K2024-07-31: 75K2024-08-15: 102K2024-08-30: 127K2024-09-13: 126K2024-09-30: 147K2024-10-15: 98K2024-10-31: 36K2024-11-15: 38K2024-11-29: 45K2024-12-13: 53K2024-12-31: 53K2025-01-15: 52K2025-01-31: 29K2025-02-14: 54K2025-02-28: 50K2025-03-14: 60K2025-03-31: 85K2025-04-15: 105K2025-04-30: 119K2025-05-15: 209K2025-05-30: 214K2025-06-13: 363K2025-06-30: 518K2025-07-15: 818K
the 15 Jul 2025 report24 earlier reportsnormal: 91K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 12 Aug 2025

Nutex Health had 905K shares sold short in the 31 Jul 2025 report, 12× the same report last year.

This period
905K (the 31 Jul 2025 report)
Normal report (median of 24 earlier)
91K
Typical spread (median absolute deviation)
39K
How far from its usual level
+14.0
Same report last year
75K
History used
1,204 days
2024-07-31: 75K2024-08-15: 102K2024-08-30: 127K2024-09-13: 126K2024-09-30: 147K2024-10-15: 98K2024-10-31: 36K2024-11-15: 38K2024-11-29: 45K2024-12-13: 53K2024-12-31: 53K2025-01-15: 52K2025-01-31: 29K2025-02-14: 54K2025-02-28: 50K2025-03-14: 60K2025-03-31: 85K2025-04-15: 105K2025-04-30: 119K2025-05-15: 209K2025-05-30: 214K2025-06-13: 363K2025-06-30: 518K2025-07-15: 818K2025-07-31: 905K
the 31 Jul 2025 report24 earlier reportsnormal: 91K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Institutional holdings: Many funds opening a new position became public on 14 Aug 2025

Nutex Health saw 55 13F filers open a new position in the quarter ended 30 Jun 2025, against none in the same quarter last year.

This period
55 (the quarter ended 30 Jun 2025)
Normal quarter (median of 8 earlier)
8
Typical spread (median absolute deviation)
2.5
How far from its usual level
+12.7
Same quarter last year
0
History used
1,096 days
2023-06-30: 182023-09-30: 72023-12-31: 72024-03-31: 52024-06-30: 02024-09-30: 102024-12-31: 152025-03-31: 92025-06-30: 55
the quarter ended 30 Jun 20258 earlier quartersnormal: 8

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Short interest and volume: Short interest spike became public on 27 Aug 2025

Nutex Health had 892K shares sold short in the 15 Aug 2025 report, 8.8× the same report last year.

This period
892K (the 15 Aug 2025 report)
Normal report (median of 24 earlier)
100K
Typical spread (median absolute deviation)
48K
How far from its usual level
+11.2
Same report last year
102K
History used
1,219 days
2024-08-15: 102K2024-08-30: 127K2024-09-13: 126K2024-09-30: 147K2024-10-15: 98K2024-10-31: 36K2024-11-15: 38K2024-11-29: 45K2024-12-13: 53K2024-12-31: 53K2025-01-15: 52K2025-01-31: 29K2025-02-14: 54K2025-02-28: 50K2025-03-14: 60K2025-03-31: 85K2025-04-15: 105K2025-04-30: 119K2025-05-15: 209K2025-05-30: 214K2025-06-13: 363K2025-06-30: 518K2025-07-15: 818K2025-07-31: 905K2025-08-15: 892K
the 15 Aug 2025 report24 earlier reportsnormal: 100K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 11 Sep 2025

Nutex Health had 1.1M shares sold short in the 29 Aug 2025 report, 8.8× the same report last year.

This period
1.1M (the 29 Aug 2025 report)
Normal report (median of 24 earlier)
102K
Typical spread (median absolute deviation)
51K
How far from its usual level
+13.5
Same report last year
127K
History used
1,233 days
2024-08-30: 127K2024-09-13: 126K2024-09-30: 147K2024-10-15: 98K2024-10-31: 36K2024-11-15: 38K2024-11-29: 45K2024-12-13: 53K2024-12-31: 53K2025-01-15: 52K2025-01-31: 29K2025-02-14: 54K2025-02-28: 50K2025-03-14: 60K2025-03-31: 85K2025-04-15: 105K2025-04-30: 119K2025-05-15: 209K2025-05-30: 214K2025-06-13: 363K2025-06-30: 518K2025-07-15: 818K2025-07-31: 905K2025-08-15: 892K2025-08-29: 1.1M
the 29 Aug 2025 report24 earlier reportsnormal: 102K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 25 Sep 2025

Nutex Health had 1.0M shares sold short in the 15 Sep 2025 report, 8.2× the same report last year.

This period
1.0M (the 15 Sep 2025 report)
Normal report (median of 24 earlier)
102K
Typical spread (median absolute deviation)
54K
How far from its usual level
+11.6
Same report last year
126K
History used
1,250 days
2024-09-13: 126K2024-09-30: 147K2024-10-15: 98K2024-10-31: 36K2024-11-15: 38K2024-11-29: 45K2024-12-13: 53K2024-12-31: 53K2025-01-15: 52K2025-01-31: 29K2025-02-14: 54K2025-02-28: 50K2025-03-14: 60K2025-03-31: 85K2025-04-15: 105K2025-04-30: 119K2025-05-15: 209K2025-05-30: 214K2025-06-13: 363K2025-06-30: 518K2025-07-15: 818K2025-07-31: 905K2025-08-15: 892K2025-08-29: 1.1M2025-09-15: 1.0M
the 15 Sep 2025 report24 earlier reportsnormal: 102K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 Oct 2025

Nutex Health had 1.0M shares sold short in the 30 Sep 2025 report, 6.9× the same report last year.

This period
1.0M (the 30 Sep 2025 report)
Normal report (median of 24 earlier)
102K
Typical spread (median absolute deviation)
61K
How far from its usual level
+10.1
Same report last year
147K
History used
1,265 days
2024-09-30: 147K2024-10-15: 98K2024-10-31: 36K2024-11-15: 38K2024-11-29: 45K2024-12-13: 53K2024-12-31: 53K2025-01-15: 52K2025-01-31: 29K2025-02-14: 54K2025-02-28: 50K2025-03-14: 60K2025-03-31: 85K2025-04-15: 105K2025-04-30: 119K2025-05-15: 209K2025-05-30: 214K2025-06-13: 363K2025-06-30: 518K2025-07-15: 818K2025-07-31: 905K2025-08-15: 892K2025-08-29: 1.1M2025-09-15: 1.0M2025-09-30: 1.0M
the 30 Sep 2025 report24 earlier reportsnormal: 102K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 25 Oct 2025

Nutex Health had 949K shares sold short in the 15 Oct 2025 report, 9.7× the same report last year.

This period
949K (the 15 Oct 2025 report)
Normal report (median of 24 earlier)
102K
Typical spread (median absolute deviation)
65K
How far from its usual level
+8.8
Same report last year
98K
History used
1,280 days
2024-10-15: 98K2024-10-31: 36K2024-11-15: 38K2024-11-29: 45K2024-12-13: 53K2024-12-31: 53K2025-01-15: 52K2025-01-31: 29K2025-02-14: 54K2025-02-28: 50K2025-03-14: 60K2025-03-31: 85K2025-04-15: 105K2025-04-30: 119K2025-05-15: 209K2025-05-30: 214K2025-06-13: 363K2025-06-30: 518K2025-07-15: 818K2025-07-31: 905K2025-08-15: 892K2025-08-29: 1.1M2025-09-15: 1.0M2025-09-30: 1.0M2025-10-15: 949K
the 15 Oct 2025 report24 earlier reportsnormal: 102K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Institutional holdings: Many funds opening a new position became public on 14 Nov 2025

Nutex Health saw 28 13F filers open a new position in the quarter ended 30 Sep 2025, 2.8× the same quarter last year.

This period
28 (the quarter ended 30 Sep 2025)
Normal quarter (median of 8 earlier)
8
Typical spread (median absolute deviation)
2.5
How far from its usual level
+5.4
Same quarter last year
10
History used
1,188 days
2023-09-30: 72023-12-31: 72024-03-31: 52024-06-30: 02024-09-30: 102024-12-31: 152025-03-31: 92025-06-30: 552025-09-30: 28
the quarter ended 30 Sep 20258 earlier quartersnormal: 8

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Short interest and volume: Short interest spike became public on 13 Nov 2025

Nutex Health had 839K shares sold short in the 31 Oct 2025 report, 24× the same report last year.

This period
839K (the 31 Oct 2025 report)
Normal report (median of 24 earlier)
112K
Typical spread (median absolute deviation)
80K
How far from its usual level
+6.2
Same report last year
36K
History used
1,296 days
2024-10-31: 36K2024-11-15: 38K2024-11-29: 45K2024-12-13: 53K2024-12-31: 53K2025-01-15: 52K2025-01-31: 29K2025-02-14: 54K2025-02-28: 50K2025-03-14: 60K2025-03-31: 85K2025-04-15: 105K2025-04-30: 119K2025-05-15: 209K2025-05-30: 214K2025-06-13: 363K2025-06-30: 518K2025-07-15: 818K2025-07-31: 905K2025-08-15: 892K2025-08-29: 1.1M2025-09-15: 1.0M2025-09-30: 1.0M2025-10-15: 949K2025-10-31: 839K
the 31 Oct 2025 report24 earlier reportsnormal: 112K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Financials: Quarterly revenue change became public on 20 Nov 2025

Nutex Health reported revenue of $267.8M for the quarter ended 30 Sep 2025, 3.4× the same quarter last year.

This period
$267.8M (the quarter ended 30 Sep 2025)
Normal quarter (median of 8 earlier)
$77.4M
Typical spread (median absolute deviation)
$12.4M
How far from its usual level
+10.4
Same quarter last year
$78.8M
History used
3,470 days
2023-09-30: $62.7M2023-12-31: $69.7M2024-03-31: $67.5M2024-06-30: $76.1M2024-09-30: $78.8M2024-12-31: $257.6M2025-03-31: $211.8M2025-06-30: $244.0M2025-09-30: $267.8M
the quarter ended 30 Sep 20258 earlier quartersnormal: $77.4M

Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

Check it at the source: SEC EDGAR quarterly reports.

Short interest and volume: Short interest spike became public on 26 Nov 2025

Nutex Health had 806K shares sold short in the 14 Nov 2025 report, 21× the same report last year.

This period
806K (the 14 Nov 2025 report)
Normal report (median of 24 earlier)
164K
Typical spread (median absolute deviation)
123K
How far from its usual level
+3.5
Same report last year
38K
History used
1,310 days
2024-11-15: 38K2024-11-29: 45K2024-12-13: 53K2024-12-31: 53K2025-01-15: 52K2025-01-31: 29K2025-02-14: 54K2025-02-28: 50K2025-03-14: 60K2025-03-31: 85K2025-04-15: 105K2025-04-30: 119K2025-05-15: 209K2025-05-30: 214K2025-06-13: 363K2025-06-30: 518K2025-07-15: 818K2025-07-31: 905K2025-08-15: 892K2025-08-29: 1.1M2025-09-15: 1.0M2025-09-30: 1.0M2025-10-15: 949K2025-10-31: 839K2025-11-14: 806K
the 14 Nov 2025 report24 earlier reportsnormal: 164K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

16 May 2023confirmed

Confirmed across sources Filings + Financials and Short interest and volume

Nutex Health (NUTX): had 12.4M shares sold short in the 14 Apr 2023 report, 1,557× the same report last year, while it reported revenue of $56.3M for the quarter ended 31 Mar 2023, 9.1× the same quarter last year. Two unrelated kinds of activity within 14 days.

  • Short interest and volume: Short interest spike, became public on 26 Apr 2023
  • Financials: Quarterly revenue change, became public on 16 May 2023
  • Short interest and volume: Short interest spike, became public on 10 May 2023
2022-04-14: 7,9652022-04-29: 946K2022-05-13: 252K2022-05-31: 398K2022-06-15: 1.8M2022-06-30: 2.2M2022-07-15: 2.9M2022-07-29: 2.6M2022-08-15: 2.9M2022-08-31: 3.0M2022-09-15: 4.2M2022-09-30: 3.3M2022-10-14: 3.7M2022-10-31: 3.1M2022-11-15: 1.4M2022-11-30: 3.1M2022-12-15: 2.9M2022-12-30: 6.9M2023-01-13: 7.0M2023-01-31: 6.6M2023-02-15: 6.0M2023-02-28: 6.8M2023-03-15: 6.8M2023-03-31: 10.7M2023-04-14: 12.4M
The 14 Apr 2023 report against the 24 reports before it. this reportearliernormal: 3.0M
See the evidence (3 changes)

Short interest and volume: Short interest spike became public on 26 Apr 2023

Nutex Health had 12.4M shares sold short in the 14 Apr 2023 report, 1,557× the same report last year.

This period
12.4M (the 14 Apr 2023 report)
Normal report (median of 24 earlier)
3.0M
Typical spread (median absolute deviation)
1.4M
How far from its usual level
+4.4
Same report last year
7,965
History used
365 days
2022-04-14: 7,9652022-04-29: 946K2022-05-13: 252K2022-05-31: 398K2022-06-15: 1.8M2022-06-30: 2.2M2022-07-15: 2.9M2022-07-29: 2.6M2022-08-15: 2.9M2022-08-31: 3.0M2022-09-15: 4.2M2022-09-30: 3.3M2022-10-14: 3.7M2022-10-31: 3.1M2022-11-15: 1.4M2022-11-30: 3.1M2022-12-15: 2.9M2022-12-30: 6.9M2023-01-13: 7.0M2023-01-31: 6.6M2023-02-15: 6.0M2023-02-28: 6.8M2023-03-15: 6.8M2023-03-31: 10.7M2023-04-14: 12.4M
the 14 Apr 2023 report24 earlier reportsnormal: 3.0M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Financials: Quarterly revenue change became public on 16 May 2023

Nutex Health reported revenue of $56.3M for the quarter ended 31 Mar 2023, 9.1× the same quarter last year.

This period
$56.3M (the quarter ended 31 Mar 2023)
Normal quarter (median of 8 earlier)
$6.1M
Typical spread (median absolute deviation)
$2.4M
How far from its usual level
+14.1
Same quarter last year
$6.2M
History used
4,657 days
2021-03-31: $2.0M2021-06-30: $5.3M2021-09-30: $5.6M2021-12-31: $5.9M2022-03-31: $6.2M2022-06-30: $58.0M2022-09-30: $29.0M2022-12-31: $53.7M2023-03-31: $56.3M
the quarter ended 31 Mar 20238 earlier quartersnormal: $6.1M

Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

Check it at the source: SEC EDGAR quarterly reports.

Short interest and volume: Short interest spike became public on 10 May 2023

Nutex Health had 12.3M shares sold short in the 28 Apr 2023 report, 13× the same report last year.

This period
12.3M (the 28 Apr 2023 report)
Normal report (median of 24 earlier)
3.1M
Typical spread (median absolute deviation)
1.5M
How far from its usual level
+4.1
Same report last year
946K
History used
379 days
2022-04-29: 946K2022-05-13: 252K2022-05-31: 398K2022-06-15: 1.8M2022-06-30: 2.2M2022-07-15: 2.9M2022-07-29: 2.6M2022-08-15: 2.9M2022-08-31: 3.0M2022-09-15: 4.2M2022-09-30: 3.3M2022-10-14: 3.7M2022-10-31: 3.1M2022-11-15: 1.4M2022-11-30: 3.1M2022-12-15: 2.9M2022-12-30: 6.9M2023-01-13: 7.0M2023-01-31: 6.6M2023-02-15: 6.0M2023-02-28: 6.8M2023-03-15: 6.8M2023-03-31: 10.7M2023-04-14: 12.4M2023-04-28: 12.3M
the 28 Apr 2023 report24 earlier reportsnormal: 3.1M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 10 Nov 2026Financials change

    spent $5.2M on capital projects in the quarter ended 30 Sep 2026, 17× the same quarter last year.

    Same quarter last year: $302K; its normal quarter is $684K.

    See the evidence
    This period
    $5.2M (the quarter ended 30 Sep 2026)
    Normal quarter (median of 8 earlier)
    $684K
    Typical spread (median absolute deviation)
    $450K
    How far from its usual level
    +4.5
    Same quarter last year
    $302K
    History used
    5,387 days
    2024-09-30: $617K2024-12-31: $395K2025-03-31: $64K2025-06-30: $751K2025-09-30: $302K2025-12-31: $1.4M2026-03-31: $1.2M2026-06-30: $2.5M2026-09-30: $5.2M
    the quarter ended 30 Sep 20268 earlier quartersnormal: $684K

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  2. 31 Aug 2026Filings record

    Material cybersecurity incident

  3. 24 Mar 2026Insiders record

    Jaumot Frank E (director) bought 150 shares of NUTX ($14,034) (dated 23 Mar 2026)

  4. 24 Mar 2026Insiders record

    Hosseinion Warren (President) bought 252 shares of NUTX ($23,706) (dated 23 Mar 2026)

  5. 19 Mar 2026Insiders record

    Spears Kelvin (director) bought 10 shares of NUTX ($945) (dated 18 Mar 2026)

  6. 17 Mar 2026Insiders record

    Montgomery Pamela W. (Chief Legal Officer-Healthcare) bought 79 shares of NUTX ($7,021) (dated 16 Mar 2026)

  7. 29 Nov 2025Insiders record

    Bates Jon Christian (Chief Financial Officer) bought 750 shares of NUTX ($102,532) (dated 28 Nov 2025)

  8. 26 Nov 2025Short interest and volume change

    had 806K shares sold short in the 14 Nov 2025 report, 21× the same report last year.

    Same report last year: 38K; its normal report is 164K.

    See the evidence
    This period
    806K (the 14 Nov 2025 report)
    Normal report (median of 24 earlier)
    164K
    Typical spread (median absolute deviation)
    123K
    How far from its usual level
    +3.5
    Same report last year
    38K
    History used
    1,310 days
    2024-11-15: 38K2024-11-29: 45K2024-12-13: 53K2024-12-31: 53K2025-01-15: 52K2025-01-31: 29K2025-02-14: 54K2025-02-28: 50K2025-03-14: 60K2025-03-31: 85K2025-04-15: 105K2025-04-30: 119K2025-05-15: 209K2025-05-30: 214K2025-06-13: 363K2025-06-30: 518K2025-07-15: 818K2025-07-31: 905K2025-08-15: 892K2025-08-29: 1.1M2025-09-15: 1.0M2025-09-30: 1.0M2025-10-15: 949K2025-10-31: 839K2025-11-14: 806K
    the 14 Nov 2025 report24 earlier reportsnormal: 164K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  9. 20 Nov 2025Financials change

    reported revenue of $267.8M for the quarter ended 30 Sep 2025, 3.4× the same quarter last year.

    Same quarter last year: $78.8M; its normal quarter is $77.4M.

    See the evidence
    This period
    $267.8M (the quarter ended 30 Sep 2025)
    Normal quarter (median of 8 earlier)
    $77.4M
    Typical spread (median absolute deviation)
    $12.4M
    How far from its usual level
    +10.4
    Same quarter last year
    $78.8M
    History used
    3,470 days
    2023-09-30: $62.7M2023-12-31: $69.7M2024-03-31: $67.5M2024-06-30: $76.1M2024-09-30: $78.8M2024-12-31: $257.6M2025-03-31: $211.8M2025-06-30: $244.0M2025-09-30: $267.8M
    the quarter ended 30 Sep 20258 earlier quartersnormal: $77.4M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  10. 17 Nov 2025Filings record

    Report will be filed late

  11. 14 Nov 2025Institutional holdings change

    saw 28 13F filers open a new position in the quarter ended 30 Sep 2025, 2.8× the same quarter last year.

    Same quarter last year: 10; its normal quarter is 8.

    See the evidence
    This period
    28 (the quarter ended 30 Sep 2025)
    Normal quarter (median of 8 earlier)
    8
    Typical spread (median absolute deviation)
    2.5
    How far from its usual level
    +5.4
    Same quarter last year
    10
    History used
    1,188 days
    2023-09-30: 72023-12-31: 72024-03-31: 52024-06-30: 02024-09-30: 102024-12-31: 152025-03-31: 92025-06-30: 552025-09-30: 28
    the quarter ended 30 Sep 20258 earlier quartersnormal: 8

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  12. 13 Nov 2025Short interest and volume change

    had 839K shares sold short in the 31 Oct 2025 report, 24× the same report last year.

    Same report last year: 36K; its normal report is 112K.

    See the evidence
    This period
    839K (the 31 Oct 2025 report)
    Normal report (median of 24 earlier)
    112K
    Typical spread (median absolute deviation)
    80K
    How far from its usual level
    +6.2
    Same report last year
    36K
    History used
    1,296 days
    2024-10-31: 36K2024-11-15: 38K2024-11-29: 45K2024-12-13: 53K2024-12-31: 53K2025-01-15: 52K2025-01-31: 29K2025-02-14: 54K2025-02-28: 50K2025-03-14: 60K2025-03-31: 85K2025-04-15: 105K2025-04-30: 119K2025-05-15: 209K2025-05-30: 214K2025-06-13: 363K2025-06-30: 518K2025-07-15: 818K2025-07-31: 905K2025-08-15: 892K2025-08-29: 1.1M2025-09-15: 1.0M2025-09-30: 1.0M2025-10-15: 949K2025-10-31: 839K
    the 31 Oct 2025 report24 earlier reportsnormal: 112K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  13. 25 Oct 2025Short interest and volume change

    had 949K shares sold short in the 15 Oct 2025 report, 9.7× the same report last year.

    Same report last year: 98K; its normal report is 102K.

    See the evidence
    This period
    949K (the 15 Oct 2025 report)
    Normal report (median of 24 earlier)
    102K
    Typical spread (median absolute deviation)
    65K
    How far from its usual level
    +8.8
    Same report last year
    98K
    History used
    1,280 days
    2024-10-15: 98K2024-10-31: 36K2024-11-15: 38K2024-11-29: 45K2024-12-13: 53K2024-12-31: 53K2025-01-15: 52K2025-01-31: 29K2025-02-14: 54K2025-02-28: 50K2025-03-14: 60K2025-03-31: 85K2025-04-15: 105K2025-04-30: 119K2025-05-15: 209K2025-05-30: 214K2025-06-13: 363K2025-06-30: 518K2025-07-15: 818K2025-07-31: 905K2025-08-15: 892K2025-08-29: 1.1M2025-09-15: 1.0M2025-09-30: 1.0M2025-10-15: 949K
    the 15 Oct 2025 report24 earlier reportsnormal: 102K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  14. 20 Oct 2025Filings record

    Delisting notice or listing transfer

  15. 10 Oct 2025Short interest and volume change

    had 1.0M shares sold short in the 30 Sep 2025 report, 6.9× the same report last year.

    Same report last year: 147K; its normal report is 102K.

    See the evidence
    This period
    1.0M (the 30 Sep 2025 report)
    Normal report (median of 24 earlier)
    102K
    Typical spread (median absolute deviation)
    61K
    How far from its usual level
    +10.1
    Same report last year
    147K
    History used
    1,265 days
    2024-09-30: 147K2024-10-15: 98K2024-10-31: 36K2024-11-15: 38K2024-11-29: 45K2024-12-13: 53K2024-12-31: 53K2025-01-15: 52K2025-01-31: 29K2025-02-14: 54K2025-02-28: 50K2025-03-14: 60K2025-03-31: 85K2025-04-15: 105K2025-04-30: 119K2025-05-15: 209K2025-05-30: 214K2025-06-13: 363K2025-06-30: 518K2025-07-15: 818K2025-07-31: 905K2025-08-15: 892K2025-08-29: 1.1M2025-09-15: 1.0M2025-09-30: 1.0M
    the 30 Sep 2025 report24 earlier reportsnormal: 102K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  16. 25 Sep 2025Short interest and volume change

    had 1.0M shares sold short in the 15 Sep 2025 report, 8.2× the same report last year.

    Same report last year: 126K; its normal report is 102K.

    See the evidence
    This period
    1.0M (the 15 Sep 2025 report)
    Normal report (median of 24 earlier)
    102K
    Typical spread (median absolute deviation)
    54K
    How far from its usual level
    +11.6
    Same report last year
    126K
    History used
    1,250 days
    2024-09-13: 126K2024-09-30: 147K2024-10-15: 98K2024-10-31: 36K2024-11-15: 38K2024-11-29: 45K2024-12-13: 53K2024-12-31: 53K2025-01-15: 52K2025-01-31: 29K2025-02-14: 54K2025-02-28: 50K2025-03-14: 60K2025-03-31: 85K2025-04-15: 105K2025-04-30: 119K2025-05-15: 209K2025-05-30: 214K2025-06-13: 363K2025-06-30: 518K2025-07-15: 818K2025-07-31: 905K2025-08-15: 892K2025-08-29: 1.1M2025-09-15: 1.0M
    the 15 Sep 2025 report24 earlier reportsnormal: 102K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  17. 22 Sep 2025Filings record

    Director or officer change

  18. 11 Sep 2025Short interest and volume change

    had 1.1M shares sold short in the 29 Aug 2025 report, 8.8× the same report last year.

    Same report last year: 127K; its normal report is 102K.

    See the evidence
    This period
    1.1M (the 29 Aug 2025 report)
    Normal report (median of 24 earlier)
    102K
    Typical spread (median absolute deviation)
    51K
    How far from its usual level
    +13.5
    Same report last year
    127K
    History used
    1,233 days
    2024-08-30: 127K2024-09-13: 126K2024-09-30: 147K2024-10-15: 98K2024-10-31: 36K2024-11-15: 38K2024-11-29: 45K2024-12-13: 53K2024-12-31: 53K2025-01-15: 52K2025-01-31: 29K2025-02-14: 54K2025-02-28: 50K2025-03-14: 60K2025-03-31: 85K2025-04-15: 105K2025-04-30: 119K2025-05-15: 209K2025-05-30: 214K2025-06-13: 363K2025-06-30: 518K2025-07-15: 818K2025-07-31: 905K2025-08-15: 892K2025-08-29: 1.1M
    the 29 Aug 2025 report24 earlier reportsnormal: 102K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  19. 4 Sep 2025Filings record

    Director or officer change

  20. 27 Aug 2025Short interest and volume change

    had 892K shares sold short in the 15 Aug 2025 report, 8.8× the same report last year.

    Same report last year: 102K; its normal report is 100K.

    See the evidence
    This period
    892K (the 15 Aug 2025 report)
    Normal report (median of 24 earlier)
    100K
    Typical spread (median absolute deviation)
    48K
    How far from its usual level
    +11.2
    Same report last year
    102K
    History used
    1,219 days
    2024-08-15: 102K2024-08-30: 127K2024-09-13: 126K2024-09-30: 147K2024-10-15: 98K2024-10-31: 36K2024-11-15: 38K2024-11-29: 45K2024-12-13: 53K2024-12-31: 53K2025-01-15: 52K2025-01-31: 29K2025-02-14: 54K2025-02-28: 50K2025-03-14: 60K2025-03-31: 85K2025-04-15: 105K2025-04-30: 119K2025-05-15: 209K2025-05-30: 214K2025-06-13: 363K2025-06-30: 518K2025-07-15: 818K2025-07-31: 905K2025-08-15: 892K
    the 15 Aug 2025 report24 earlier reportsnormal: 100K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  21. 20 Aug 2025Filings record

    Earlier financial statements can no longer be relied on

  22. 20 Aug 2025Filings record

    Delisting notice or listing transfer

  23. 14 Aug 2025several at once

    saw 55 13F filers open a new position in the quarter ended 30 Jun 2025, against none in the same quarter last year; it also had 949K shares sold short in the 15 Oct 2025 report, 9.7× the same report last year; and it reported revenue of $267.8M for the quarter ended 30 Sep 2025, 3.4× the same quarter last year. Three unrelated kinds of activity within 126 days.

    See the evidence (12 changes)

    Short interest and volume: Short interest spike became public on 25 Jul 2025

    Nutex Health had 818K shares sold short in the 15 Jul 2025 report, 7.5× the same report last year.

    This period
    818K (the 15 Jul 2025 report)
    Normal report (median of 24 earlier)
    91K
    Typical spread (median absolute deviation)
    38K
    How far from its usual level
    +12.7
    Same report last year
    108K
    History used
    1,188 days
    2024-07-15: 108K2024-07-31: 75K2024-08-15: 102K2024-08-30: 127K2024-09-13: 126K2024-09-30: 147K2024-10-15: 98K2024-10-31: 36K2024-11-15: 38K2024-11-29: 45K2024-12-13: 53K2024-12-31: 53K2025-01-15: 52K2025-01-31: 29K2025-02-14: 54K2025-02-28: 50K2025-03-14: 60K2025-03-31: 85K2025-04-15: 105K2025-04-30: 119K2025-05-15: 209K2025-05-30: 214K2025-06-13: 363K2025-06-30: 518K2025-07-15: 818K
    the 15 Jul 2025 report24 earlier reportsnormal: 91K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 12 Aug 2025

    Nutex Health had 905K shares sold short in the 31 Jul 2025 report, 12× the same report last year.

    This period
    905K (the 31 Jul 2025 report)
    Normal report (median of 24 earlier)
    91K
    Typical spread (median absolute deviation)
    39K
    How far from its usual level
    +14.0
    Same report last year
    75K
    History used
    1,204 days
    2024-07-31: 75K2024-08-15: 102K2024-08-30: 127K2024-09-13: 126K2024-09-30: 147K2024-10-15: 98K2024-10-31: 36K2024-11-15: 38K2024-11-29: 45K2024-12-13: 53K2024-12-31: 53K2025-01-15: 52K2025-01-31: 29K2025-02-14: 54K2025-02-28: 50K2025-03-14: 60K2025-03-31: 85K2025-04-15: 105K2025-04-30: 119K2025-05-15: 209K2025-05-30: 214K2025-06-13: 363K2025-06-30: 518K2025-07-15: 818K2025-07-31: 905K
    the 31 Jul 2025 report24 earlier reportsnormal: 91K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Institutional holdings: Many funds opening a new position became public on 14 Aug 2025

    Nutex Health saw 55 13F filers open a new position in the quarter ended 30 Jun 2025, against none in the same quarter last year.

    This period
    55 (the quarter ended 30 Jun 2025)
    Normal quarter (median of 8 earlier)
    8
    Typical spread (median absolute deviation)
    2.5
    How far from its usual level
    +12.7
    Same quarter last year
    0
    History used
    1,096 days
    2023-06-30: 182023-09-30: 72023-12-31: 72024-03-31: 52024-06-30: 02024-09-30: 102024-12-31: 152025-03-31: 92025-06-30: 55
    the quarter ended 30 Jun 20258 earlier quartersnormal: 8

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

    Short interest and volume: Short interest spike became public on 27 Aug 2025

    Nutex Health had 892K shares sold short in the 15 Aug 2025 report, 8.8× the same report last year.

    This period
    892K (the 15 Aug 2025 report)
    Normal report (median of 24 earlier)
    100K
    Typical spread (median absolute deviation)
    48K
    How far from its usual level
    +11.2
    Same report last year
    102K
    History used
    1,219 days
    2024-08-15: 102K2024-08-30: 127K2024-09-13: 126K2024-09-30: 147K2024-10-15: 98K2024-10-31: 36K2024-11-15: 38K2024-11-29: 45K2024-12-13: 53K2024-12-31: 53K2025-01-15: 52K2025-01-31: 29K2025-02-14: 54K2025-02-28: 50K2025-03-14: 60K2025-03-31: 85K2025-04-15: 105K2025-04-30: 119K2025-05-15: 209K2025-05-30: 214K2025-06-13: 363K2025-06-30: 518K2025-07-15: 818K2025-07-31: 905K2025-08-15: 892K
    the 15 Aug 2025 report24 earlier reportsnormal: 100K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 11 Sep 2025

    Nutex Health had 1.1M shares sold short in the 29 Aug 2025 report, 8.8× the same report last year.

    This period
    1.1M (the 29 Aug 2025 report)
    Normal report (median of 24 earlier)
    102K
    Typical spread (median absolute deviation)
    51K
    How far from its usual level
    +13.5
    Same report last year
    127K
    History used
    1,233 days
    2024-08-30: 127K2024-09-13: 126K2024-09-30: 147K2024-10-15: 98K2024-10-31: 36K2024-11-15: 38K2024-11-29: 45K2024-12-13: 53K2024-12-31: 53K2025-01-15: 52K2025-01-31: 29K2025-02-14: 54K2025-02-28: 50K2025-03-14: 60K2025-03-31: 85K2025-04-15: 105K2025-04-30: 119K2025-05-15: 209K2025-05-30: 214K2025-06-13: 363K2025-06-30: 518K2025-07-15: 818K2025-07-31: 905K2025-08-15: 892K2025-08-29: 1.1M
    the 29 Aug 2025 report24 earlier reportsnormal: 102K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 25 Sep 2025

    Nutex Health had 1.0M shares sold short in the 15 Sep 2025 report, 8.2× the same report last year.

    This period
    1.0M (the 15 Sep 2025 report)
    Normal report (median of 24 earlier)
    102K
    Typical spread (median absolute deviation)
    54K
    How far from its usual level
    +11.6
    Same report last year
    126K
    History used
    1,250 days
    2024-09-13: 126K2024-09-30: 147K2024-10-15: 98K2024-10-31: 36K2024-11-15: 38K2024-11-29: 45K2024-12-13: 53K2024-12-31: 53K2025-01-15: 52K2025-01-31: 29K2025-02-14: 54K2025-02-28: 50K2025-03-14: 60K2025-03-31: 85K2025-04-15: 105K2025-04-30: 119K2025-05-15: 209K2025-05-30: 214K2025-06-13: 363K2025-06-30: 518K2025-07-15: 818K2025-07-31: 905K2025-08-15: 892K2025-08-29: 1.1M2025-09-15: 1.0M
    the 15 Sep 2025 report24 earlier reportsnormal: 102K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 10 Oct 2025

    Nutex Health had 1.0M shares sold short in the 30 Sep 2025 report, 6.9× the same report last year.

    This period
    1.0M (the 30 Sep 2025 report)
    Normal report (median of 24 earlier)
    102K
    Typical spread (median absolute deviation)
    61K
    How far from its usual level
    +10.1
    Same report last year
    147K
    History used
    1,265 days
    2024-09-30: 147K2024-10-15: 98K2024-10-31: 36K2024-11-15: 38K2024-11-29: 45K2024-12-13: 53K2024-12-31: 53K2025-01-15: 52K2025-01-31: 29K2025-02-14: 54K2025-02-28: 50K2025-03-14: 60K2025-03-31: 85K2025-04-15: 105K2025-04-30: 119K2025-05-15: 209K2025-05-30: 214K2025-06-13: 363K2025-06-30: 518K2025-07-15: 818K2025-07-31: 905K2025-08-15: 892K2025-08-29: 1.1M2025-09-15: 1.0M2025-09-30: 1.0M
    the 30 Sep 2025 report24 earlier reportsnormal: 102K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 25 Oct 2025

    Nutex Health had 949K shares sold short in the 15 Oct 2025 report, 9.7× the same report last year.

    This period
    949K (the 15 Oct 2025 report)
    Normal report (median of 24 earlier)
    102K
    Typical spread (median absolute deviation)
    65K
    How far from its usual level
    +8.8
    Same report last year
    98K
    History used
    1,280 days
    2024-10-15: 98K2024-10-31: 36K2024-11-15: 38K2024-11-29: 45K2024-12-13: 53K2024-12-31: 53K2025-01-15: 52K2025-01-31: 29K2025-02-14: 54K2025-02-28: 50K2025-03-14: 60K2025-03-31: 85K2025-04-15: 105K2025-04-30: 119K2025-05-15: 209K2025-05-30: 214K2025-06-13: 363K2025-06-30: 518K2025-07-15: 818K2025-07-31: 905K2025-08-15: 892K2025-08-29: 1.1M2025-09-15: 1.0M2025-09-30: 1.0M2025-10-15: 949K
    the 15 Oct 2025 report24 earlier reportsnormal: 102K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Institutional holdings: Many funds opening a new position became public on 14 Nov 2025

    Nutex Health saw 28 13F filers open a new position in the quarter ended 30 Sep 2025, 2.8× the same quarter last year.

    This period
    28 (the quarter ended 30 Sep 2025)
    Normal quarter (median of 8 earlier)
    8
    Typical spread (median absolute deviation)
    2.5
    How far from its usual level
    +5.4
    Same quarter last year
    10
    History used
    1,188 days
    2023-09-30: 72023-12-31: 72024-03-31: 52024-06-30: 02024-09-30: 102024-12-31: 152025-03-31: 92025-06-30: 552025-09-30: 28
    the quarter ended 30 Sep 20258 earlier quartersnormal: 8

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

    Short interest and volume: Short interest spike became public on 13 Nov 2025

    Nutex Health had 839K shares sold short in the 31 Oct 2025 report, 24× the same report last year.

    This period
    839K (the 31 Oct 2025 report)
    Normal report (median of 24 earlier)
    112K
    Typical spread (median absolute deviation)
    80K
    How far from its usual level
    +6.2
    Same report last year
    36K
    History used
    1,296 days
    2024-10-31: 36K2024-11-15: 38K2024-11-29: 45K2024-12-13: 53K2024-12-31: 53K2025-01-15: 52K2025-01-31: 29K2025-02-14: 54K2025-02-28: 50K2025-03-14: 60K2025-03-31: 85K2025-04-15: 105K2025-04-30: 119K2025-05-15: 209K2025-05-30: 214K2025-06-13: 363K2025-06-30: 518K2025-07-15: 818K2025-07-31: 905K2025-08-15: 892K2025-08-29: 1.1M2025-09-15: 1.0M2025-09-30: 1.0M2025-10-15: 949K2025-10-31: 839K
    the 31 Oct 2025 report24 earlier reportsnormal: 112K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Financials: Quarterly revenue change became public on 20 Nov 2025

    Nutex Health reported revenue of $267.8M for the quarter ended 30 Sep 2025, 3.4× the same quarter last year.

    This period
    $267.8M (the quarter ended 30 Sep 2025)
    Normal quarter (median of 8 earlier)
    $77.4M
    Typical spread (median absolute deviation)
    $12.4M
    How far from its usual level
    +10.4
    Same quarter last year
    $78.8M
    History used
    3,470 days
    2023-09-30: $62.7M2023-12-31: $69.7M2024-03-31: $67.5M2024-06-30: $76.1M2024-09-30: $78.8M2024-12-31: $257.6M2025-03-31: $211.8M2025-06-30: $244.0M2025-09-30: $267.8M
    the quarter ended 30 Sep 20258 earlier quartersnormal: $77.4M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

    Short interest and volume: Short interest spike became public on 26 Nov 2025

    Nutex Health had 806K shares sold short in the 14 Nov 2025 report, 21× the same report last year.

    This period
    806K (the 14 Nov 2025 report)
    Normal report (median of 24 earlier)
    164K
    Typical spread (median absolute deviation)
    123K
    How far from its usual level
    +3.5
    Same report last year
    38K
    History used
    1,310 days
    2024-11-15: 38K2024-11-29: 45K2024-12-13: 53K2024-12-31: 53K2025-01-15: 52K2025-01-31: 29K2025-02-14: 54K2025-02-28: 50K2025-03-14: 60K2025-03-31: 85K2025-04-15: 105K2025-04-30: 119K2025-05-15: 209K2025-05-30: 214K2025-06-13: 363K2025-06-30: 518K2025-07-15: 818K2025-07-31: 905K2025-08-15: 892K2025-08-29: 1.1M2025-09-15: 1.0M2025-09-30: 1.0M2025-10-15: 949K2025-10-31: 839K2025-11-14: 806K
    the 14 Nov 2025 report24 earlier reportsnormal: 164K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  24. 14 Aug 2025Institutional holdings change

    saw 55 13F filers open a new position in the quarter ended 30 Jun 2025, against none in the same quarter last year.

    See the evidence
    This period
    55 (the quarter ended 30 Jun 2025)
    Normal quarter (median of 8 earlier)
    8
    Typical spread (median absolute deviation)
    2.5
    How far from its usual level
    +12.7
    Same quarter last year
    0
    History used
    1,096 days
    2023-06-30: 182023-09-30: 72023-12-31: 72024-03-31: 52024-06-30: 02024-09-30: 102024-12-31: 152025-03-31: 92025-06-30: 55
    the quarter ended 30 Jun 20258 earlier quartersnormal: 8

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  25. 14 Aug 2025Filings record

    Report will be filed late

  26. 12 Aug 2025Short interest and volume change

    had 905K shares sold short in the 31 Jul 2025 report, 12× the same report last year.

    Same report last year: 75K; its normal report is 91K.

    See the evidence
    This period
    905K (the 31 Jul 2025 report)
    Normal report (median of 24 earlier)
    91K
    Typical spread (median absolute deviation)
    39K
    How far from its usual level
    +14.0
    Same report last year
    75K
    History used
    1,204 days
    2024-07-31: 75K2024-08-15: 102K2024-08-30: 127K2024-09-13: 126K2024-09-30: 147K2024-10-15: 98K2024-10-31: 36K2024-11-15: 38K2024-11-29: 45K2024-12-13: 53K2024-12-31: 53K2025-01-15: 52K2025-01-31: 29K2025-02-14: 54K2025-02-28: 50K2025-03-14: 60K2025-03-31: 85K2025-04-15: 105K2025-04-30: 119K2025-05-15: 209K2025-05-30: 214K2025-06-13: 363K2025-06-30: 518K2025-07-15: 818K2025-07-31: 905K
    the 31 Jul 2025 report24 earlier reportsnormal: 91K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  27. 25 Jul 2025Short interest and volume change

    had 818K shares sold short in the 15 Jul 2025 report, 7.5× the same report last year.

    Same report last year: 108K; its normal report is 91K.

    See the evidence
    This period
    818K (the 15 Jul 2025 report)
    Normal report (median of 24 earlier)
    91K
    Typical spread (median absolute deviation)
    38K
    How far from its usual level
    +12.7
    Same report last year
    108K
    History used
    1,188 days
    2024-07-15: 108K2024-07-31: 75K2024-08-15: 102K2024-08-30: 127K2024-09-13: 126K2024-09-30: 147K2024-10-15: 98K2024-10-31: 36K2024-11-15: 38K2024-11-29: 45K2024-12-13: 53K2024-12-31: 53K2025-01-15: 52K2025-01-31: 29K2025-02-14: 54K2025-02-28: 50K2025-03-14: 60K2025-03-31: 85K2025-04-15: 105K2025-04-30: 119K2025-05-15: 209K2025-05-30: 214K2025-06-13: 363K2025-06-30: 518K2025-07-15: 818K
    the 15 Jul 2025 report24 earlier reportsnormal: 91K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  28. 11 Jul 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  29. 11 Jul 2025Filings record

    Director or officer change

  30. 21 May 2025Filings record

    Changed its auditor

  31. 15 May 2025Financials change

    reported revenue of $211.8M for the quarter ended 31 Mar 2025, 3.1× the same quarter last year.

    Same quarter last year: $67.5M; its normal quarter is $68.6M.

    See the evidence
    This period
    $211.8M (the quarter ended 31 Mar 2025)
    Normal quarter (median of 8 earlier)
    $68.6M
    Typical spread (median absolute deviation)
    $8.6M
    How far from its usual level
    +11.3
    Same quarter last year
    $67.5M
    History used
    3,287 days
    2023-03-31: $56.3M2023-06-30: $58.9M2023-09-30: $62.7M2023-12-31: $69.7M2024-03-31: $67.5M2024-06-30: $76.1M2024-09-30: $78.8M2024-12-31: $257.6M2025-03-31: $211.8M
    the quarter ended 31 Mar 20258 earlier quartersnormal: $68.6M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  32. 25 Apr 2025Filings record

    Changed its auditor

  33. 15 Apr 2025Insiders record

    Bates Jon Christian (Chief Financial Officer) bought 1,000 shares of NUTX ($81,810) (dated 14 Apr 2025)

  34. 1 Apr 2025Financials change

    reported revenue of $257.6M for the quarter ended 31 Dec 2024, 3.7× the same quarter last year.

    Same quarter last year: $69.7M; its normal quarter is $65.1M.

    See the evidence
    This period
    $257.6M (the quarter ended 31 Dec 2024)
    Normal quarter (median of 8 earlier)
    $65.1M
    Typical spread (median absolute deviation)
    $7.5M
    How far from its usual level
    +17.4
    Same quarter last year
    $69.7M
    History used
    5,298 days
    2022-12-31: $53.7M2023-03-31: $56.3M2023-06-30: $58.9M2023-09-30: $62.7M2023-12-31: $69.7M2024-03-31: $67.5M2024-06-30: $76.1M2024-09-30: $78.8M2024-12-31: $257.6M
    the quarter ended 31 Dec 20248 earlier quartersnormal: $65.1M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  35. 27 Aug 2024Insiders record

    Bates Jon Christian (Chief Financial Officer) bought 1,350 shares of NUTX ($28,971) (dated 26 Aug 2024)

  36. 22 Aug 2024Insiders record

    DeTillio Joshua (Chief Operating Officer) bought 1,875 shares of NUTX ($33,210) (dated 21 Aug 2024)

  37. 18 Jun 2024Filings record

    Delisting notice or listing transfer

  38. 14 Jun 2024Insiders record

    DeTillio Joshua (Chief Operating Officer) bought 20,000 shares of NUTX ($10,800) (dated 13 Jun 2024)

  39. 31 May 2024Insiders record

    Vo Thomas T. (Chief Executive Officer) bought 72,478 shares of NUTX ($50,366) (dated 30 May 2024)

  40. 24 May 2024Filings record

    Delisting notice or listing transfer

Showing the newest 40 of 143 entries; narrow the window or the kind of data to see older ones.

Not listed: 114 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001479681
Ticker
NUTX
Domain
nutexhealth.com
Hq location
TX|HOUSTON|77056 (1 unverified)
Name
ABQ Hospital, LLC, AHP Health Management Services, Inc, Albuquerque ER & Hospital, LLC, Alexandria Hospital LLC and 47 more
Wikipedia
Nutex Health
  • SEC Form 13F institutional holdings162 data points30 Jun 2022 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)189 records30 Mar 2016 to 17 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)986 data points30 Jun 2010 to 2 Nov 2026
  • SEC Form 4 insider transactions33 records, 96 data points9 Sep 2020 to 18 Sep 2026
  • FINRA short interest (twice monthly)330 data points14 Apr 2022 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)2328 data points4 Apr 2022 to 20 Nov 2026
  • Wikipedia pageviews11 data points11 Nov 2026 to 21 Nov 2026